Category

News

Exocrine Pancreatic Insufficiency (EPI) & Pancreatic EnzymesNewsPatient ResourcesWebinarsWebinars: Exocrine Pancreatic Insufficiency (EPI) & Pancreatic Enzymes
March 8, 2019

Pancreatic Enzyme Replacement Therapy – Worldwide Expert Gives Pancreatitis Patients New Information on Treating Pancreatic Insufficiency

Busting the Myths about Pancreatic Enzymes for Pancreatitis and EPI Dr. Steven Freedman, MD, Ph.D., a worldwide expert on pancreatic disease and cystic fibrosis, presents Busting the Myths about Pancreatic Enzymes for Pancreatitis. In this webinar, the fifth in Mission: Cure’s Patient and Family Webinar Series, Dr. Freedman explains: What causes exocrine pancreatic insufficiency (EPI)? How is EPI diagnosed and treated? When…
Read More
News
March 1, 2019

Potential Chronic Pancreatitis Treatments Identified

On February 28, 2019, Rare Disease Day, an alliance of leading life-science companies, in partnership with Mission: Cure, announced the promising results of a 4-month "datathon" aimed at identifying potential treatments for chronic pancreatitis. Using artificial intelligence and statistical techniques, datathon participants identified 4 existing, approved drugs as repurposing candidates worth testing as possible cures for pancreatitis. New Pancreatitis Treatment…
Read More
NewsPatient ResourcesWebinarsWebinars: Exocrine Pancreatic Insufficiency (EPI) & Pancreatic Enzymes
February 19, 2019

Pancreatic Enzymes for Pancreatitis: Upcoming Webinar

Confused about pancreatic enzymes? Mission: Cure invites you to join us on Thursday, March 7, 2019 at 2:00 p.m. EST for our next webinar Busting the Myths about Pancreatic Enzymes for Pancreatitis If you think you have pancreatic insufficiency due to pancreatitis or another disorder, you won't want to miss Mission: Cure's next webinar. Get the information you need about exocrine pancreatic…
Read More
NewsPatient ResourcesTPIATWebinarsWebinars: TPIAT
January 11, 2019

Will Pancreas Surgery Cure My Pancreatitis? Doctors Explain TPIAT

Mission: Cure's webinar, TPIAT: Should I Have My Pancreas Removed?, discusses pancreas surgery to reduce chronic pain from pancreatitis.  This is the fourth broadcast in Mission: Cure’s Patient and Family Webinar Series. In this webinar replay you can hear Dr. Melena Bellin of the University of Minnesota explain: Who should consider TPIAT (Total Pancreatectomy & Islet Auto-Transplantation) The selection criteria The TPIAT…
Read More
BlogGeneticsNewsPatient Resources
December 13, 2018

“Is Pancreatitis in Your Genes?” Webinar Q&A

We had so many questions during our webinar on the genetics of pancreatitis, which can be viewed here, that we could not answer them all during the session. We didn't want to leave questions unanswered, so here are Dr. Mark Haupt and Dr. David Whitcomb's answers to the questions we didn’t get to: (more…)
Read More
NewsPatient ResourcesRepurposing DrugsWebinars
December 9, 2018

Curing Pancreatitis: It’s Time for a New Approach!

https://youtu.be/BOmLjiVIX6c On December 8th, Mission: Cure hosted an informational webinar for chronic and recurrent acute pancreatitis patients, their families and clinicians on their new approach to curing pancreatitis. It featured co-directors Megan Golden and Linda Martin, who gave presentations on the gap Mission: Cure is working to address, their innovative financing model, and how patients and families can get involved…
Read More
GeneticsNewsPatient Resources
November 14, 2018

Pancreatitis and Genetics: New Science Shows Pancreatitis Likely to be Hereditary

https://youtu.be/dLrEmdmgaLQ Pancreatitis is Often Caused by Genetics In November 2018, Mission: Cure hosted a webinar for chronic and recurrent acute pancreatitis patients on new genetic discoveries related to pancreatitis. It featured presentations by Dr. David Whitcomb of the University of Pittsburgh Medical Center and Dr. Mark Haupt of Ariel Precision Medicine, experts in pancreatitis genetics. The doctors answered many questions…
Read More
News
September 11, 2018

blackbear Will Accept Courage Award at Mission: Cure LA Fundraiser to Cure Pancreatitis

Read More
News
July 11, 2018

N=1 Drug Discovery Pact: Mission: Cure’s New Partnership with Perlara

Mission: Cure believes that new innovations in medical research are key to achieving our goal of curing chronic pancreatitis. For this reason, we strive to leverage and support advances in genomics and precision medicine and aim to collaborate with forward-thinking and mission-driven organizations. Today, we are excited to announce our partnership with Perlara, a rare disease drug discovery platform company working with…
Read More
If you or a loved one is experiencing pain due to chronic pancreatitis, here is an opportunity to get your voice heard and potentially shape the drug development and regulatory process! On Monday July 9th, 2018 from 10:00am to 4:00pm, FDA is hosting a public meeting on Patient-Focused Drug Development for Chronic Pain. The goal of this meeting is to better understand and incorporate patients’ voice in drug development and evaluation for chronic pain. FDA is interested in hearing about 1) the symptoms of chronic pain that matter most to patients and 2) patients’ perspectives on current approaches to treatment of chronic pain, particularly from those using analgesic medications, other medications, and non-pharmacological interventions or therapies. Due to limited capacity, in-person registration has closed, but registration to attend via webcast is still open. Webcast participants can also provide input through virtual comments. We call upon interested chronic pancreatitis patients to find more information and register at https://bit.ly/2HkylYZ and bring the much-needed voice of chronic pancreatitis patients to the meeting.
News
June 25, 2018

Register for the FDA Public Meeting on Chronic Pain!

To register and see more information regarding the session on chronic pain, please visit: https://bit.ly/2HkylYZ. On the day of the meeting, registered patients will be able to access the webcast here. Get your voice heard: If you are unable to making the public meeting, you can still contribute through written comments on the Federal Register Notice for this meeting that will…
Read More